NCI Division of Cancer Control and Population Sciences

Do you have bold ideas to advance research and accelerate progress in communicating evolving cancer information? Join us to collaboratively explore innovative solutions. Learn more: https://lnkd.in/eFXCbNeN

Do you have any evidence-based cancer control interventions that you would like to have featured on the Evidence-Based Cancer Control Programs (EBCCP) website? The National Cancer Institute invites you to submit your program for consideration.    The EBCCP website is a searchable database offering easy access to research-tested materials to implement cancer prevention and control interventions in clinical or community settings: https://go.nih.gov/4xQ5wDJ You can submit your content for inclusion on the website to help increase your program’s reach and visibility: https://go.nih.gov/fheso2i

The Cancer Pathology Coding Histology And Registration Terminology (CancerPathCHART) team launched CPC*Search, an interactive webtool for searching tumor combinations of site, histology, and behavior with terms and codes in the 2024 Cancer PathCHART standards for cancer surveillance in North America. Visit https://lnkd.in/eNv7WkMu to get started today! What Is Cancer PathCHART? Cancer Pathology Coding Histology And Registration Terminology (Cancer PathCHART) is a first-of-its-kind initiative in North America and around the world to update cancer surveillance standards for tumor site, histology, and behavior code combinations and associated terminology. Why Is It Needed? The foundational data items of site, histology, and behavior are the basis for all subsequent data abstraction for a tumor (e.g., stage, treatment, outcomes). Accurate data are essential for the evaluation, management, research, and surveillance of cancer patients. What Will Its Impact Be? This vital online resource will help cancer registrars, clinicians, pathologists, researchers, and developers use the same terms and coding standards, making cancer surveillance more accurately reflect medical practice without altering cancer registration workflows, all to better support the critical data necessary for public health monitoring and cancer research. #CancerSurveillance #Registrars #Pathologists #CancerResearchers #Histology #CancerData

Join the Office of Cancer Survivorship on June 18, 2024, from 2-3:30 p.m. ET for this #NationalCancerSurvivorsMonth OCS Director’s Series webinar - Survivor Voices: The Vital Role of Survivors in Advancing #CancerSurvivorship Research, featuring survivors, researchers, and advocates.   Register at https://go.nih.gov/67NWbOz.

Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions - NOT-MD-23-003 - seeks to support research focusing on the design & implementation of interventions that address immigrant-specific factors to promote health advantages and reduce #HealthDisparities. Learn more about this funding opportunity at https://go.nih.gov/O6lJuAd.

Healthcare Delivery Research Program's Dr. Michael Halpern joined the JCO After Hours podcast with Office of Cancer Survivorship's Dr. Emily Tonorezos and others to discuss myths and presumptions about cancer survivorship. Listen to the full episode here: https://lnkd.in/egz75HUc

WEBINAR: Join us on May 7, 3-4pm ET, to learn more about leveraging population-based registries for genomic studies of pediatric cancer. Dr. Philip Lupo will be presenting https://lnkd.in/eRa6sdZB #PediatricCancer #NextGenSequencing #CancerEpidemiology

As NCI’s bridge to public health research, practice, and policy, the Division of Cancer Control and Population Sciences (DCCPS) plays a unique role in reducing the burden of cancer in America. DCCPS, an extramural division, has the lead responsibility at NCI for supporting research in surveillance, epidemiology, health services, behavioral science, and cancer survivorship. Learn more about cancer control and population sciences funding opportunities at https://lnkd.in/ej6yRr7C.     #NIHfunding #CancerResearch #CancerControl 

April is Alcohol Awareness Month! DCCPS aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, and developing and/or evaluating alcohol policy approaches. Check out this Notice of Special Interest (NOSI) – Population Approaches to Reducing Alcohol-related Cancer Risk: https://lnkd.in/e4WKMvw3

NCI’s Surveillance Research Program just released SEER’s latest data and statistics! https://lnkd.in/etmyHx9G The SEER website now shows data and statistics from the November 2023 SEER submission and U.S. Mortality through 2022.   This includes: 📊 SEER Incidence Data, 1975-2021 (with an updated page about the impact of COVID on incidence data and the new technical report) 📉 SEER*Explorer with statistics through 2021 📈 Cancer Stat Fact Sheets, including 2024 projections: more than 2 million total new cancer diagnoses expected this year 👩💻 Cancer Query System databases for Incidence, Survival, and Mortality We also included the End of Decade Populations Changes with this release. The Surveillance Research Program website (surveillance.cancer.gov) has also been updated to reflect the new statistics, including: New versions of Joinpoint Updated Delay Method documentation Please note that the DevCan/Lifetime Risk statistics were not included in this release. Since the early 1970s, the Surveillance, Epidemiology, and End Results (SEER) Program has been an invaluable resource for statistics on cancer in the United States, tracking and reporting trends in incidence, mortality, survival, and prevalence. SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). Updated annually and provided as a public service in print and electronic formats, SEER data are used by thousands of researchers, clinicians, public health officials, legislators, policymakers, community groups, and the public. Thank you for your partnership, and please feel free to share with your networks!